Mintun, Mark A.
Eli Lilly and Company,
United States
2025 Rank: 19954
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 933 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19954 | 20348 |
| Total Cites | 3998 | 4647 |
| H-index | 31 | 34 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 360 | 370 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 1063 | 1156 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2919 | 3188 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.46 |
| Self-Citation Percentage |
13.97%
|
|
Mintun, Mark A.
Washington University in St. Louis,
United States
2024 Rank: 20279
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 999 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20279 | 20519 |
| Total Cites | 3321 | 3876 |
| H-index | 29 | 32 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 289 | 307 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 936 | 1028 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2492 | 2727 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.42 |
| Self-Citation Percentage |
14.32%
|
|
Mintun, Mark A.
Eli Lilly and Company,
United States
2023 Rank: 15738
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 860 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15738 | 14317 |
| Total Cites | 3241 | 3805 |
| H-index | 29 | 33 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 288 | 305 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 957 | 1042 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2458 | 2709 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.40 |
| Self-Citation Percentage |
14.82%
|
|
Mintun, Mark A.
Washington University in St. Louis,
United States
2022 Rank: 23958
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 1389 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23958 | 25086 |
| Total Cites | 3039 | 3489 |
| H-index | 32 | 34 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 150 | 160 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 820 | 882 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2267 | 2478 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.41 |
| Self-Citation Percentage |
12.90%
|
|
Mintun, Mark A.
Avid Radiopharmaceuticals, Inc,
United States
2021 Rank: 36219
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 2018 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36219 | 37313 |
| Total Cites | 4227 | 4880 |
| H-index | 38 | 41 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 118 | 131 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 1057 | 1142 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3215 | 3547 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.38 |
| Self-Citation Percentage |
13.38%
|
|
Related Profiles
Featured Profiles
Partner with Us
📢 Reach a targeted audience of science enthusiasts and professionals through our platform. Contact our marketing team:
business@topscinet.com cc: top2percentscientist@gmail.comGet a custom proposal tailored to your banner ad goals.
Partner with Us
📢 Partner with us and reach a targeted audience of science enthusiasts and professionals through our platform. Your company/institute’s banner could be here.